Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
A rare morphologic variant of cervical adenocarcinoma composed of clear and hobnail cells. It is associated with in utero exposure to diethylstilbestrol (DES).
Biomarker and diagnostic research for cervical clear cell adenocarcinoma has been reported in the published literature.
1 clinical trial registered. Interventions under study include biologic therapy. Pipeline includes 1 PHASE2. Research is primarily industry-sponsored.
50 publications have been identified in PubMed for cervical clear cell adenocarcinoma. Research spans Case Report / Case Series (38%), Clinical Trial Publication (20%), and Epidemiology / Natural History (14%).
Research Type | Count | % of Total |
|---|---|---|
Patient case studies | 19 | 38% |
Data assembled from 3 of 12 sources · Last updated Sep 19, 2026, 4:35 PM UTC
Clinical study results |
10 |
20% |
Disease patterns and progression | 7 | 14% |
Research summaries | 6 | 12% |
Laboratory research | 5 | 10% |
Testing and diagnosis research | 3 | 6% |
Andrade LALA (2026). [PMID: 41731708](https://pubmed.ncbi.nlm.nih.gov/41731708/). *International journal of surgical pathology*. [Case Report / Case Series]
Liu R (2026). [PMID: 41758478](https://pubmed.ncbi.nlm.nih.gov/41758478/). *Discover oncology*. [Case Report / Case Series]
Saab R (2026). [PMID: 41650791](https://pubmed.ncbi.nlm.nih.gov/41650791/). *Gynecologic oncology*. [Review / Meta-Analysis]
Huang J (2026). [PMID: 41810507](https://pubmed.ncbi.nlm.nih.gov/41810507/). *Cancer medicine*. [Epidemiology / Natural History]
Shan Y (2026). [PMID: 40853110](https://pubmed.ncbi.nlm.nih.gov/40853110/). *International journal of surgery (London, England)*. [Clinical Trial Publication]
Bou Zerdan M (2026). [PMID: 41785530](https://pubmed.ncbi.nlm.nih.gov/41785530/). *Gynecologic oncology*. [Epidemiology / Natural History]
Chen L (2026). [PMID: 41588855](https://pubmed.ncbi.nlm.nih.gov/41588855/). *Cancer medicine*. [Clinical Trial Publication]
Cue L (2026). [PMID: 31536198](https://pubmed.ncbi.nlm.nih.gov/31536198/). *Unknown Journal*. [Review / Meta-Analysis]
Chae YK (2026). [PMID: 41672597](https://pubmed.ncbi.nlm.nih.gov/41672597/). *Journal for immunotherapy of cancer*. [Clinical Trial Publication]
Parisi G (2026). [PMID: 42074625](https://pubmed.ncbi.nlm.nih.gov/42074625/). *J Clin Med*. [Review / Meta-Analysis]